EGF stimulation plays a role in matrix remodeling through the ERK and ILK/GSK-3 pathways in ovarian surface epithelial cells [16], and the combined targeting of endothelin and EGF receptors has been shown to increase antitumor activity in ovarian cancer [6, 17]. The gene discussed is EGF; the disease is ovarian carcinoma.